The Influence of Adjuvant Medical Treatment of Peritoneal Endometriosis on the Outcome of IVF. A Prospective Randomized Analysis.
NCT ID: NCT01682642
Last Updated: 2015-03-20
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
120 participants
INTERVENTIONAL
2012-03-31
2014-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PGL5001 Proof of Concept Study in Inflammatory Endometriosis
NCT01630252
IVF Versus Surgery for Endometriosis Related Infertility
NCT04743167
Study to Compare Peritoneal Ablation by Excision Only and Excision With the Use of an Adhesion Barrier
NCT02165917
Immediate Intra Uterine Isemination (IUI) Versus Expectant Management in Postoperative Endometriosis Patients
NCT02636400
Endometrial Injury for Assisted Reproduction
NCT01132144
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Zoladex
After surgical vaporization of endometriosis patients are treated with Zoladex for 3 months.
Zoladex
after surgical vaporization patients are treated with Zoladex for 3 months before starting IVF treatment
vaporization only
Surgical vaporization of the endometriosis is done and patients start IVF without additional treatment.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Zoladex
after surgical vaporization patients are treated with Zoladex for 3 months before starting IVF treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 1,2, 3e IVF cycle
* endometriosis stage I and II
* younger than 38 years
Exclusion Criteria
* uterine pathology
* endocrinological diseases and problems
18 Years
38 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Onze Lieve Vrouw Hospital
OTHER
AZ Jan Palfijn Gent
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Decleer Wim
gynecologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wim Decleer, gynecologist
Role: PRINCIPAL_INVESTIGATOR
Fertility Center AZ Jan Palfijn Gent
Paul Devroey, Professor
Role: STUDY_CHAIR
Fertility Center AZ Jan Palfijn Gent
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AZ Jan Palfijn
Ghent, Oost-vlaanderen, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2012-000784-25
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.